 | • レポートコード：MRC2-11QY14338 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は処方用皮膚科薬のグローバル市場について調査・分析したレポートです。種類別（抗ニキビ薬、老化防止薬、皮膚炎薬、脱毛薬、乾癬薬、皮膚がん薬、肝斑薬、脂漏症薬）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別処方用皮膚科薬の競争状況、市場シェア ・世界の処方用皮膚科薬市場：種類別市場規模 2015年-2020年（抗ニキビ薬、老化防止薬、皮膚炎薬、脱毛薬、乾癬薬、皮膚がん薬、肝斑薬、脂漏症薬） ・世界の処方用皮膚科薬市場：種類別市場規模予測 2021年-2026年（抗ニキビ薬、老化防止薬、皮膚炎薬、脱毛薬、乾癬薬、皮膚がん薬、肝斑薬、脂漏症薬） ・世界の処方用皮膚科薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界の処方用皮膚科薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米の処方用皮膚科薬市場分析：米国、カナダ ・ヨーロッパの処方用皮膚科薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの処方用皮膚科薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の処方用皮膚科薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの処方用皮膚科薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Johnson & Johnson、Merck、Bayer、Mylan Pharmaceuticals、Pfizer、F. Hoffmann-La Roche、Allergan、Bausch Health、PharmaDerm Pharmaceuticals、Allergan Inamed Corporation ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Prescription Dermatological Drugs Market
The global Prescription Dermatological Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Prescription Dermatological Drugs Scope and Market Size
Prescription Dermatological Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prescription Dermatological Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Prescription Dermatological Drugs market is segmented into
Anti-acne Drugs
Anti-aging Drugs
Dermatitis Drugs
Hair Loss Drugs
Psoriasis Drugs
Skin Cancer Drugs
Melasma Drugs
Seborrhea Drugs
Segment by Application, the Prescription Dermatological Drugs market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional and Country-level Analysis
The Prescription Dermatological Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Prescription Dermatological Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Prescription Dermatological Drugs Market Share Analysis
Prescription Dermatological Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Prescription Dermatological Drugs business, the date to enter into the Prescription Dermatological Drugs market, Prescription Dermatological Drugs product introduction, recent developments, etc.
The major vendors covered:
Johnson & Johnson
Merck
Bayer
Mylan Pharmaceuticals
Pfizer
F. Hoffmann-La Roche
Allergan
Bausch Health
PharmaDerm Pharmaceuticals
Allergan Inamed Corporation
1 Study Coverage
1.1 Prescription Dermatological Drugs Product Introduction
1.2 Market Segments
1.3 Key Prescription Dermatological Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Prescription Dermatological Drugs Market Size Growth Rate by Type
1.4.2 Anti-acne Drugs
1.4.3 Anti-aging Drugs
1.4.4 Dermatitis Drugs
1.4.5 Hair Loss Drugs
1.4.6 Psoriasis Drugs
1.4.7 Skin Cancer Drugs
1.4.8 Melasma Drugs
1.4.9 Seborrhea Drugs
1.5 Market by Application
1.5.1 Global Prescription Dermatological Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Prescription Dermatological Drugs Market Size, Estimates and Forecasts
2.1.1 Global Prescription Dermatological Drugs Revenue 2015-2026
2.1.2 Global Prescription Dermatological Drugs Sales 2015-2026
2.2 Global Prescription Dermatological Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Prescription Dermatological Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Prescription Dermatological Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Prescription Dermatological Drugs Competitor Landscape by Players
3.1 Prescription Dermatological Drugs Sales by Manufacturers
3.1.1 Prescription Dermatological Drugs Sales by Manufacturers (2015-2020)
3.1.2 Prescription Dermatological Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Prescription Dermatological Drugs Revenue by Manufacturers
3.2.1 Prescription Dermatological Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Prescription Dermatological Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Prescription Dermatological Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Prescription Dermatological Drugs Revenue in 2019
3.2.5 Global Prescription Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Prescription Dermatological Drugs Price by Manufacturers
3.4 Prescription Dermatological Drugs Manufacturing Base Distribution, Product Types
3.4.1 Prescription Dermatological Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Prescription Dermatological Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Prescription Dermatological Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Prescription Dermatological Drugs Market Size by Type (2015-2020)
4.1.1 Global Prescription Dermatological Drugs Sales by Type (2015-2020)
4.1.2 Global Prescription Dermatological Drugs Revenue by Type (2015-2020)
4.1.3 Prescription Dermatological Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Prescription Dermatological Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Prescription Dermatological Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Prescription Dermatological Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Prescription Dermatological Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Prescription Dermatological Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Prescription Dermatological Drugs Market Size by Application (2015-2020)
5.1.1 Global Prescription Dermatological Drugs Sales by Application (2015-2020)
5.1.2 Global Prescription Dermatological Drugs Revenue by Application (2015-2020)
5.1.3 Prescription Dermatological Drugs Price by Application (2015-2020)
5.2 Prescription Dermatological Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Prescription Dermatological Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Prescription Dermatological Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Prescription Dermatological Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Prescription Dermatological Drugs by Country
6.1.1 North America Prescription Dermatological Drugs Sales by Country
6.1.2 North America Prescription Dermatological Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Prescription Dermatological Drugs Market Facts & Figures by Type
6.3 North America Prescription Dermatological Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Prescription Dermatological Drugs by Country
7.1.1 Europe Prescription Dermatological Drugs Sales by Country
7.1.2 Europe Prescription Dermatological Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Prescription Dermatological Drugs Market Facts & Figures by Type
7.3 Europe Prescription Dermatological Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Prescription Dermatological Drugs by Region
8.1.1 Asia Pacific Prescription Dermatological Drugs Sales by Region
8.1.2 Asia Pacific Prescription Dermatological Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Prescription Dermatological Drugs Market Facts & Figures by Type
8.3 Asia Pacific Prescription Dermatological Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Prescription Dermatological Drugs by Country
9.1.1 Latin America Prescription Dermatological Drugs Sales by Country
9.1.2 Latin America Prescription Dermatological Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Prescription Dermatological Drugs Market Facts & Figures by Type
9.3 Central & South America Prescription Dermatological Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Prescription Dermatological Drugs by Country
10.1.1 Middle East and Africa Prescription Dermatological Drugs Sales by Country
10.1.2 Middle East and Africa Prescription Dermatological Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Prescription Dermatological Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Prescription Dermatological Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Description and Business Overview
11.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson & Johnson Prescription Dermatological Drugs Products Offered
11.1.5 Johnson & Johnson Related Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description and Business Overview
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Prescription Dermatological Drugs Products Offered
11.2.5 Merck Related Developments
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Description and Business Overview
11.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bayer Prescription Dermatological Drugs Products Offered
11.3.5 Bayer Related Developments
11.4 Mylan Pharmaceuticals
11.4.1 Mylan Pharmaceuticals Corporation Information
11.4.2 Mylan Pharmaceuticals Description and Business Overview
11.4.3 Mylan Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Mylan Pharmaceuticals Prescription Dermatological Drugs Products Offered
11.4.5 Mylan Pharmaceuticals Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Prescription Dermatological Drugs Products Offered
11.5.5 Pfizer Related Developments
11.6 F. Hoffmann-La Roche
11.6.1 F. Hoffmann-La Roche Corporation Information
11.6.2 F. Hoffmann-La Roche Description and Business Overview
11.6.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.6.4 F. Hoffmann-La Roche Prescription Dermatological Drugs Products Offered
11.6.5 F. Hoffmann-La Roche Related Developments
11.7 Allergan
11.7.1 Allergan Corporation Information
11.7.2 Allergan Description and Business Overview
11.7.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Allergan Prescription Dermatological Drugs Products Offered
11.7.5 Allergan Related Developments
11.8 Bausch Health
11.8.1 Bausch Health Corporation Information
11.8.2 Bausch Health Description and Business Overview
11.8.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bausch Health Prescription Dermatological Drugs Products Offered
11.8.5 Bausch Health Related Developments
11.9 PharmaDerm Pharmaceuticals
11.9.1 PharmaDerm Pharmaceuticals Corporation Information
11.9.2 PharmaDerm Pharmaceuticals Description and Business Overview
11.9.3 PharmaDerm Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.9.4 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Products Offered
11.9.5 PharmaDerm Pharmaceuticals Related Developments
11.10 Allergan Inamed Corporation
11.10.1 Allergan Inamed Corporation Corporation Information
11.10.2 Allergan Inamed Corporation Description and Business Overview
11.10.3 Allergan Inamed Corporation Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Allergan Inamed Corporation Prescription Dermatological Drugs Products Offered
11.10.5 Allergan Inamed Corporation Related Developments
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Description and Business Overview
11.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson & Johnson Prescription Dermatological Drugs Products Offered
11.1.5 Johnson & Johnson Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Prescription Dermatological Drugs Market Estimates and Projections by Region
12.1.1 Global Prescription Dermatological Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Prescription Dermatological Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Prescription Dermatological Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Prescription Dermatological Drugs Sales Forecast (2021-2026)
12.2.2 North America: Prescription Dermatological Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Prescription Dermatological Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Prescription Dermatological Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Prescription Dermatological Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Prescription Dermatological Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Prescription Dermatological Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Prescription Dermatological Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Prescription Dermatological Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Prescription Dermatological Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Prescription Dermatological Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Prescription Dermatological Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Prescription Dermatological Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Prescription Dermatological Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Prescription Dermatological Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Prescription Dermatological Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Prescription Dermatological Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Prescription Dermatological Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Prescription Dermatological Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Prescription Dermatological Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Prescription Dermatological Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Prescription Dermatological Drugs Market Segments
Table 2. Ranking of Global Top Prescription Dermatological Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Prescription Dermatological Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Anti-acne Drugs
Table 5. Major Manufacturers of Anti-aging Drugs
Table 6. Major Manufacturers of Dermatitis Drugs
Table 7. Major Manufacturers of Hair Loss Drugs
Table 8. Major Manufacturers of Psoriasis Drugs
Table 9. Major Manufacturers of Skin Cancer Drugs
Table 10. Major Manufacturers of Melasma Drugs
Table 11. Major Manufacturers of Seborrhea Drugs
Table 12. Global Prescription Dermatological Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Prescription Dermatological Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Prescription Dermatological Drugs Sales by Regions 2015-2020 (K Units)
Table 15. Global Prescription Dermatological Drugs Sales Market Share by Regions (2015-2020)
Table 16. Global Prescription Dermatological Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Prescription Dermatological Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Prescription Dermatological Drugs Sales Share by Manufacturers (2015-2020)
Table 19. Global Prescription Dermatological Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Prescription Dermatological Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prescription Dermatological Drugs as of 2019)
Table 21. Prescription Dermatological Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Prescription Dermatological Drugs Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Prescription Dermatological Drugs Price (2015-2020) (USD/Units)
Table 24. Prescription Dermatological Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Prescription Dermatological Drugs Product Type
Table 26. Date of International Manufacturers Enter into Prescription Dermatological Drugs Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Prescription Dermatological Drugs Sales by Type (2015-2020) (K Units)
Table 29. Global Prescription Dermatological Drugs Sales Share by Type (2015-2020)
Table 30. Global Prescription Dermatological Drugs Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Prescription Dermatological Drugs Revenue Share by Type (2015-2020)
Table 32. Prescription Dermatological Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Units)
Table 33. Global Prescription Dermatological Drugs Sales by Application (2015-2020) (K Units)
Table 34. Global Prescription Dermatological Drugs Sales Share by Application (2015-2020)
Table 35. North America Prescription Dermatological Drugs Sales by Country (2015-2020) (K Units)
Table 36. North America Prescription Dermatological Drugs Sales Market Share by Country (2015-2020)
Table 37. North America Prescription Dermatological Drugs Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Prescription Dermatological Drugs Revenue Market Share by Country (2015-2020)
Table 39. North America Prescription Dermatological Drugs Sales by Type (2015-2020) (K Units)
Table 40. North America Prescription Dermatological Drugs Sales Market Share by Type (2015-2020)
Table 41. North America Prescription Dermatological Drugs Sales by Application (2015-2020) (K Units)
Table 42. North America Prescription Dermatological Drugs Sales Market Share by Application (2015-2020)
Table 43. Europe Prescription Dermatological Drugs Sales by Country (2015-2020) (K Units)
Table 44. Europe Prescription Dermatological Drugs Sales Market Share by Country (2015-2020)
Table 45. Europe Prescription Dermatological Drugs Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Prescription Dermatological Drugs Revenue Market Share by Country (2015-2020)
Table 47. Europe Prescription Dermatological Drugs Sales by Type (2015-2020) (K Units)
Table 48. Europe Prescription Dermatological Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Prescription Dermatological Drugs Sales by Application (2015-2020) (K Units)
Table 50. Europe Prescription Dermatological Drugs Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Prescription Dermatological Drugs Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific Prescription Dermatological Drugs Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Prescription Dermatological Drugs Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Prescription Dermatological Drugs Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Prescription Dermatological Drugs Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific Prescription Dermatological Drugs Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Prescription Dermatological Drugs Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific Prescription Dermatological Drugs Sales Market Share by Application (2015-2020)
Table 59. Latin America Prescription Dermatological Drugs Sales by Country (2015-2020) (K Units)
Table 60. Latin America Prescription Dermatological Drugs Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Prescription Dermatological Drugs Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Prescription Dermatological Drugs Revenue Market Share by Country (2015-2020)
Table 63. Latin America Prescription Dermatological Drugs Sales by Type (2015-2020) (K Units)
Table 64. Latin America Prescription Dermatological Drugs Sales Market Share by Type (2015-2020)
Table 65. Latin America Prescription Dermatological Drugs Sales by Application (2015-2020) (K Units)
Table 66. Latin America Prescription Dermatological Drugs Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Prescription Dermatological Drugs Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa Prescription Dermatological Drugs Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Prescription Dermatological Drugs Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Prescription Dermatological Drugs Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Prescription Dermatological Drugs Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa Prescription Dermatological Drugs Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Prescription Dermatological Drugs Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa Prescription Dermatological Drugs Sales Market Share by Application (2015-2020)
Table 75. Johnson & Johnson Corporation Information
Table 76. Johnson & Johnson Description and Major Businesses
Table 77. Johnson & Johnson Prescription Dermatological Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 78. Johnson & Johnson Product
Table 79. Johnson & Johnson Recent Development
Table 80. Merck Corporation Information
Table 81. Merck Description and Major Businesses
Table 82. Merck Prescription Dermatological Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 83. Merck Product
Table 84. Merck Recent Development
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Major Businesses
Table 87. Bayer Prescription Dermatological Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 88. Bayer Product
Table 89. Bayer Recent Development
Table 90. Mylan Pharmaceuticals Corporation Information
Table 91. Mylan Pharmaceuticals Description and Major Businesses
Table 92. Mylan Pharmaceuticals Prescription Dermatological Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 93. Mylan Pharmaceuticals Product
Table 94. Mylan Pharmaceuticals Recent Development
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Major Businesses
Table 97. Pfizer Prescription Dermatological Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 98. Pfizer Product
Table 99. Pfizer Recent Development
Table 100. F. Hoffmann-La Roche Corporation Information
Table 101. F. Hoffmann-La Roche Description and Major Businesses
Table 102. F. Hoffmann-La Roche Prescription Dermatological Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 103. F. Hoffmann-La Roche Product
Table 104. F. Hoffmann-La Roche Recent Development
Table 105. Allergan Corporation Information
Table 106. Allergan Description and Major Businesses
Table 107. Allergan Prescription Dermatological Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 108. Allergan Product
Table 109. Allergan Recent Development
Table 110. Bausch Health Corporation Information
Table 111. Bausch Health Description and Major Businesses
Table 112. Bausch Health Prescription Dermatological Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 113. Bausch Health Product
Table 114. Bausch Health Recent Development
Table 115. PharmaDerm Pharmaceuticals Corporation Information
Table 116. PharmaDerm Pharmaceuticals Description and Major Businesses
Table 117. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 118. PharmaDerm Pharmaceuticals Product
Table 119. PharmaDerm Pharmaceuticals Recent Development
Table 120. Allergan Inamed Corporation Corporation Information
Table 121. Allergan Inamed Corporation Description and Major Businesses
Table 122. Allergan Inamed Corporation Prescription Dermatological Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 123. Allergan Inamed Corporation Product
Table 124. Allergan Inamed Corporation Recent Development
Table 125. Global Prescription Dermatological Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 126. Global Prescription Dermatological Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 127. Global Prescription Dermatological Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 128. Global Prescription Dermatological Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 129. North America: Prescription Dermatological Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 130. North America: Prescription Dermatological Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Europe: Prescription Dermatological Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 132. Europe: Prescription Dermatological Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Asia Pacific: Prescription Dermatological Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 134. Asia Pacific: Prescription Dermatological Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 135. Latin America: Prescription Dermatological Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 136. Latin America: Prescription Dermatological Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Middle East and Africa: Prescription Dermatological Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 138. Middle East and Africa: Prescription Dermatological Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 140. Key Challenges
Table 141. Market Risks
Table 142. Main Points Interviewed from Key Prescription Dermatological Drugs Players
Table 143. Prescription Dermatological Drugs Customers List
Table 144. Prescription Dermatological Drugs Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Prescription Dermatological Drugs Product Picture
Figure 2. Global Prescription Dermatological Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Anti-acne Drugs Product Picture
Figure 4. Anti-aging Drugs Product Picture
Figure 5. Dermatitis Drugs Product Picture
Figure 6. Hair Loss Drugs Product Picture
Figure 7. Psoriasis Drugs Product Picture
Figure 8. Skin Cancer Drugs Product Picture
Figure 9. Melasma Drugs Product Picture
Figure 10. Seborrhea Drugs Product Picture
Figure 11. Global Prescription Dermatological Drugs Sales Market Share by Application in 2020 & 2026
Figure 12. Hospital Pharmacies
Figure 13. Retail Pharmacies
Figure 14. Online Pharmacies
Figure 15. Prescription Dermatological Drugs Report Years Considered
Figure 16. Global Prescription Dermatological Drugs Market Size 2015-2026 (US$ Million)
Figure 17. Global Prescription Dermatological Drugs Sales 2015-2026 (K Units)
Figure 18. Global Prescription Dermatological Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Prescription Dermatological Drugs Sales Market Share by Region (2015-2020)
Figure 20. Global Prescription Dermatological Drugs Sales Market Share by Region in 2019
Figure 21. Global Prescription Dermatological Drugs Revenue Market Share by Region (2015-2020)
Figure 22. Global Prescription Dermatological Drugs Revenue Market Share by Region in 2019
Figure 23. Global Prescription Dermatological Drugs Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Prescription Dermatological Drugs Revenue in 2019
Figure 25. Prescription Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Prescription Dermatological Drugs Sales Market Share by Type (2015-2020)
Figure 27. Global Prescription Dermatological Drugs Sales Market Share by Type in 2019
Figure 28. Global Prescription Dermatological Drugs Revenue Market Share by Type (2015-2020)
Figure 29. Global Prescription Dermatological Drugs Revenue Market Share by Type in 2019
Figure 30. Global Prescription Dermatological Drugs Market Share by Price Range (2015-2020)
Figure 31. Global Prescription Dermatological Drugs Sales Market Share by Application (2015-2020)
Figure 32. Global Prescription Dermatological Drugs Sales Market Share by Application in 2019
Figure 33. Global Prescription Dermatological Drugs Revenue Market Share by Application (2015-2020)
Figure 34. Global Prescription Dermatological Drugs Revenue Market Share by Application in 2019
Figure 35. North America Prescription Dermatological Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 36. North America Prescription Dermatological Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America Prescription Dermatological Drugs Sales Market Share by Country in 2019
Figure 38. North America Prescription Dermatological Drugs Revenue Market Share by Country in 2019
Figure 39. U.S. Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 40. U.S. Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 42. Canada Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America Prescription Dermatological Drugs Market Share by Type in 2019
Figure 44. North America Prescription Dermatological Drugs Market Share by Application in 2019
Figure 45. Europe Prescription Dermatological Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 46. Europe Prescription Dermatological Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Prescription Dermatological Drugs Sales Market Share by Country in 2019
Figure 48. Europe Prescription Dermatological Drugs Revenue Market Share by Country in 2019
Figure 49. Germany Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Germany Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. France Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. U.K. Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 56. Italy Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 58. Russia Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe Prescription Dermatological Drugs Market Share by Type in 2019
Figure 60. Europe Prescription Dermatological Drugs Market Share by Application in 2019
Figure 61. Asia Pacific Prescription Dermatological Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 62. Asia Pacific Prescription Dermatological Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Prescription Dermatological Drugs Sales Market Share by Region in 2019
Figure 64. Asia Pacific Prescription Dermatological Drugs Revenue Market Share by Region in 2019
Figure 65. China Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. China Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. Japan Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. South Korea Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. India Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Australia Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Taiwan Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Indonesia Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Thailand Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Malaysia Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 84. Philippines Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 86. Vietnam Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific Prescription Dermatological Drugs Market Share by Type in 2019
Figure 88. Asia Pacific Prescription Dermatological Drugs Market Share by Application in 2019
Figure 89. Latin America Prescription Dermatological Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 90. Latin America Prescription Dermatological Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Prescription Dermatological Drugs Sales Market Share by Country in 2019
Figure 92. Latin America Prescription Dermatological Drugs Revenue Market Share by Country in 2019
Figure 93. Mexico Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 94. Mexico Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 96. Brazil Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 98. Argentina Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America Prescription Dermatological Drugs Market Share by Type in 2019
Figure 100. Latin America Prescription Dermatological Drugs Market Share by Application in 2019
Figure 101. Middle East and Africa Prescription Dermatological Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 102. Middle East and Africa Prescription Dermatological Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa Prescription Dermatological Drugs Sales Market Share by Country in 2019
Figure 104. Middle East and Africa Prescription Dermatological Drugs Revenue Market Share by Country in 2019
Figure 105. Turkey Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 106. Turkey Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 108. Saudi Arabia Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 110. U.A.E Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Middle East and Africa Prescription Dermatological Drugs Market Share by Type in 2019
Figure 112. Middle East and Africa Prescription Dermatological Drugs Market Share by Application in 2019
Figure 113. North America Prescription Dermatological Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. North America Prescription Dermatological Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Prescription Dermatological Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Europe Prescription Dermatological Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Prescription Dermatological Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Asia Pacific Prescription Dermatological Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Prescription Dermatological Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Latin America Prescription Dermatological Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Prescription Dermatological Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Middle East and Africa Prescription Dermatological Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
高脂血症処方薬の世界市場（～2026年） Market Analysis and Insights: Global Hyperlipidemia Prescription Drugs Market The global Hyperlipidemia Prescription Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hyperlipidemia Prescription Drugs Scope and Mar…- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…
- 止瀉薬の世界市場（～2026年） Market Analysis and Insights: Global Anti Diarrheal Drugs Market The global Anti Diarrheal Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti Diarrheal Drugs Scope and Market Size Anti Diarrheal Drugs market is…
- 抗糖尿病治療薬の世界市場（～2026年） The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for…
- 抗ニキビ薬の世界市場（～2026年） Market Analysis and Insights: Global Anti Acne Drugs Market The global Anti Acne Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti Acne Drugs Scope and Market Size Anti Acne Drugs market is segmented by Type, …